Willems L N, Kramps J A, de Water R, Stijnen T, Fleuren G J, Franken C, Dijkman J H
Eur J Respir Dis. 1986 Oct;69(4):242-7.
To evaluate the presence of antileukoprotease in the lung and its possible contribution to parenchymal protection, surgically removed lungs or lobes of 41 patients were studied. Tissue slices were stained immunohistochemically for antileukoprotease. Site and number of antileukoprotease-containing cells were recorded. To measure emphysema, the mean linear intercept of each slice was determined. Antileukoprotease was observed in bronchial epithelium and glands and in at least two types of nonciliated cells and in a few basal cells of bronchiolar epithelium. No relationship existed between the frequency of antileukoprotease positive cells in membranous bronchioles and the mean linear intercept, the smoking history or lung function except for total lung capacity. These results do not support a protective activity of antileukoprotease against emphysema, but neither do they provide evidence against it.
为评估肺中抗白细胞蛋白酶的存在及其对实质组织保护的可能作用,我们对41例患者手术切除的肺或肺叶进行了研究。组织切片进行抗白细胞蛋白酶免疫组织化学染色。记录含抗白细胞蛋白酶细胞的位置和数量。为测量肺气肿,测定了每个切片的平均线性截距。在支气管上皮、腺体以及至少两种类型的无纤毛细胞和细支气管上皮的一些基底细胞中观察到抗白细胞蛋白酶。除了肺总量外,膜性细支气管中抗白细胞蛋白酶阳性细胞的频率与平均线性截距、吸烟史或肺功能之间没有关系。这些结果不支持抗白细胞蛋白酶对肺气肿有保护作用,但也没有提供反对它的证据。